Michael Buckley is a biotechnology executive with nearly 40 years of experience leading the development and commercialization of complex biologics. Known for his ability to translate advanced science into strategic and operational success, he has played a pivotal role in bringing innovative therapies to market while guiding organizations through transformation and growth.

I’m excited to share a look at my journey leading GMP manufacturing, quality operations, and CMC strategy across biologics, cell and gene therapies, and vaccines—from facility design and C&Q to IND/BLA submissions and commercial readiness. My path has been about building strong teams, scaling robust processes, and aligning science with compliance to deliver therapies that matter. Here is my biography.